Healthcare
Live Price
Offline$3.09
-0.10% today
1Y Change
+19.78%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
WELL Health Technologies Corp. (WHTCF) is a Healthcare stock with a market cap of $1.10B and listed on OTC. The stock last traded around $3.09 and up 19.8% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +52.1%, EPS growth of -123.0%, a dividend yield of 0.0%. What stands out right now is revenue +52.1%, EPS -123.0%, free cash flow +1410.4% with operating margin 7.7% and ROIC 4.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines WHTCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WHTCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WHTCF Max Drawdown
-39.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WHTCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$302.3M
-46.9% YoY
FY Net Income
-$43.8M
-3298.5% YoY
Free Cash Flow
$19.6M
-72.1% YoY
Revenue Growth
+52.1%
EPS Growth
-123.0%
Gross Margin
37.5%
Net Margin
-0.5%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 920M | 776M | 569M | 302M |
| Gross Profit | 525M | 363M | 372M | 303M | 154M |
| Operating Income | 113M | -30M | 35M | 23M | -13M |
| EBITDA | 207M | 117M | 91M | 95M | 32M |
| Net Income | -50M | 33M | 82K | 1M | -44M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 134M | 132M | 43M | 49M | 62M |
| Total Assets | 2.1B | 1.8B | 1.4B | 1.3B | 1.3B |
| Total Liabilities | 1.1B | 878M | 563M | 504M | 554M |
| Shareholder Equity | 863M | 868M | 768M | 732M | 618M |
| Total Debt | 710M | 425M | 426M | 358M | 402M |
| Net Debt | 577M | 293M | 383M | 310M | 340M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
22M
-70.9% YoY
Capital Expenditures
3M
+58.1% YoY
Free Cash Flow
20M
-72.1% YoY
Key ratios
Gross Margin
37.5%
Operating Margin
7.7%
Net Margin
-0.5%
ROE
-0.9%
Debt / Equity
0.82x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.